Value Proposition and
Innovative Models for
Multi-Sectoral Engagement
in Global Health
PROCEEDINGS OF A WORKSHOP
Liza Hamilton and Melissa Maitin-Shepard, Rapporteurs
Forum on Public—Private Partnerships for Global Health and Safety
Board on Global Health
Health and Medicine Division
THE NATIONAL ACADEMIES PRESS
Washington, DC
www.nap.edu
THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001
This activity was supported by contracts between the National Academy of Sciences and Anheuser-Busch InBev; Becton, Dickinson and Company; Bill & Melinda Gates Foundation; Catholic Health Association of the United States; ExxonMobil; Global Health Innovative Technology Fund; Intel Corporation; Johnson & Johnson; Medtronic; Merck & Co., Inc.; Novartis Foundation; PATH; Procter & Gamble Company; Safaricom; United Nations Foundation; University of Notre Dame; The UPS Foundation; U.S. Agency for International Development; U.S. Centers for Disease Control and Prevention; and U.S. Department of State. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
International Standard Book Number-13: 978-0-309-49483-0
International Standard Book Number-10: 0-309-49483-4
Digital Object Identifier: https://doi.org/10.17226/25501
Additional copies of this publication are available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Copyright 2020 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
Suggested citation: National Academies of Sciences, Engineering, and Medicine. 2020. Value proposition and innovative models for multi-sectoral engagement in global health: Proceedings of a workshop. Washington, DC: The National Academies Press. https://doi.org/10.17226/25501.
The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Marcia McNutt is president.
The National Academy of Engineering was established in 1964 under the charter of the National Academy of Sciences to bring the practices of engineering to advising the nation. Members are elected by their peers for extraordinary contributions to engineering. Dr. John L. Anderson is president.
The National Academy of Medicine (formerly the Institute of Medicine) was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distinguished contributions to medicine and health. Dr. Victor J. Dzau is president.
The three Academies work together as the National Academies of Sciences, Engineering, and Medicine to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine.
Learn more about the National Academies of Sciences, Engineering, and Medicine at www.nationalacademies.org.
Consensus Study Reports published by the National Academies of Sciences, Engineering, and Medicine document the evidence-based consensus on the study’s statement of task by an authoring committee of experts. Reports typically include findings, conclusions, and recommendations based on information gathered by the committee and the committee’s deliberations. Each report has been subjected to a rigorous and independent peer-review process and it represents the position of the National Academies on the statement of task.
Proceedings published by the National Academies of Sciences, Engineering, and Medicine chronicle the presentations and discussions at a workshop, symposium, or other event convened by the National Academies. The statements and opinions contained in proceedings are those of the participants and are not endorsed by other participants, the planning committee, or the National Academies.
For information about other products and activities of the National Academies, please visit www.nationalacademies.org/about/whatwedo.
PLANNING COMMITTEE ON VALUE PROPOSITION AND INNOVATIVE MODELS FOR MULTI-SECTORAL ENGAGEMENT IN GLOBAL HEALTH1
CLARION JOHNSON (Co-Chair), Private Consultant, ExxonMobil
SEEMA KUMAR (Co-Chair), Vice President, Innovation, Global Health, and Science Policy Communication, Johnson & Johnson
CARA BRADLEY, Chief Corporate Engagement Officer, PATH
BRENDA D. COLATRELLA, Associate Vice President, Corporate Responsibility; President, Merck Foundation; President, Merck Patient Assistance Program, Merck & Co., Inc.
JAMES COUGHLAN, Loaned Executive, The UPS Foundation
GABRIELLA MORRIS, Senior Vice President, Strategic Partnerships and UNICEF Ventures, U.S. Fund for UNICEF
SHAWN STANDRIDGE, Corporate Medical Director, Procter & Gamble Company
MARY LOU VALDEZ, Associate Commissioner, International Programs; Director, Office of International Programs, U.S. Food and Drug Administration
Consultant to the Committee
HANNAH KETTLER, Senior Program Officer, Life Sciences Partnerships, Bill & Melinda Gates Foundation
___________________
1 The National Academies of Sciences, Engineering, and Medicine’s planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for this published Proceedings of a Workshop rests with the workshop rapporteurs and the institution.
This page intentionally left blank.
FORUM ON PUBLIC–PRIVATE PARTNERSHIPS FOR GLOBAL HEALTH AND SAFETY1
JO IVEY BOUFFORD (Co-Chair), Clinical Professor, New York University College of Global Public Health
CLARION JOHNSON (Co-Chair), Private Consultant, ExxonMobil
ANN AERTS, Head, Novartis Foundation
SIR GEORGE ALLEYNE, Director Emeritus, Pan American Health Organization; Chancellor Emeritus, University of the West Indies
NATASHA BILIMORIA, Director, U.S. Strategy, Gavi, the Vaccine Alliance
DEBORAH L. BIRX, U.S. Global AIDS Coordinator and U.S. Special Representative for Global Health Diplomacy, The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), U.S. Department of State
SIMON BLAND, Director, New York Liaison Office, UNAIDS
CARA BRADLEY, Chief Corporate Engagement Officer, PATH
STEPHEN CHEGE, Director, Corporate Affairs, Safaricom
ROBERT CLAY, Vice President, Save the Children
BRENDA D. COLATRELLA, Associate Vice President, Corporate Responsibility; President, Merck Foundation; President, Merck Patient Assistance Program, Merck & Co., Inc.
BRUCE COMPTON, Senior Director of International Outreach, Catholic Health Association of the United States
KATE DODSON, Vice President for Global Health Strategy, United Nations Foundation
RENUKA GADDE, Vice President, Global Health, Becton, Dickinson and Company
ROGER GLASS, Director, Fogarty International Center
ALLISON GOLDBERG, Executive Director, Anheuser-Busch InBev Foundation
TREVOR GUNN, Vice President, International Relations, Medtronic (until March 2019)
JESSICA HERZSTEIN, Preventive Medicine Specialist
JAMES JONES, Executive Director, ExxonMobil Foundation
SEEMA KUMAR, Vice President, Innovation, Global Health, and Science Policy Communication, Johnson & Johnson
REBECCA MARTIN, Director of the Center for Global Health, U.S. Centers for Disease Control and Prevention
___________________
1 The National Academies of Sciences, Engineering, and Medicine’s forums and roundtables do not issue, review, or approve individual documents. The responsibility for this published Proceedings of a Workshop rests with the workshop rapporteurs and the institution.
EDUARDO MARTINEZ, President, The UPS Foundation, and Chief Diversity & Inclusion Officer, UPS
JOHN MONAHAN, Senior Fellow and Senior Advisor for Global Health Initiatives to the President, Georgetown University
GABRIELLA MORRIS, Senior Vice President, Strategic Partnerships and UNICEF Ventures, U.S. Fund for UNICEF
ANDRIN OSWALD, Director, Life Sciences Partnerships, Bill & Melinda Gates Foundation
REGINA RABINOVICH, ExxonMobil Malaria Scholar in Residence, Harvard T.H. Chan School of Public Health, Harvard University
SCOTT C. RATZAN, Senior Fellow, Mossavar-Rahmani Center for Business and Government, Harvard Kennedy School
BT SLINGSBY, Chief Executive Officer and Executive Director, Global Health Innovative Technology Fund (until December 2018)
KATHERINE TAYLOR, Associate Director and Director, Global Health Training, Eck Institute for Global Health, University of Notre Dame
TADATAKA “TACHI” YAMADA, Venture Partner, Frazier Healthcare Partners
Health and Medicine Division Staff
RACHEL M. TAYLOR, Senior Program Officer and Forum Director (until December 2018)
LIZA RENEE HAMILTON, Program Officer and Forum Director (from March 2019)
KATHERINE PEREZ, Research Associate
CLAIRE MOERDER, Senior Program Assistant (from March 2019)
DANIEL CESNALIS, Financial Associate (until June 2019)
JULIE PAVLIN, Director, Board on Global Health
Consultant
MELISSA MAITIN-SHEPARD, Rapporteur
Reviewers
This Proceedings of a Workshop was reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise. The purpose of this independent review is to provide candid and critical comments that will assist the National Academies of Sciences, Engineering, and Medicine in making each published proceedings as sound as possible and to ensure that it meets the institutional standards for quality, objectivity, evidence, and responsiveness to the charge. The review comments and draft manuscript remain confidential to protect the integrity of the process.
We thank the following individuals for their review of this proceedings:
Although the reviewers listed above provided many constructive comments and suggestions, they were not asked to endorse the content of the proceedings nor did they see the final draft before its release. The review of this proceedings was overseen by HUGH H. TILSON, University of North Carolina. He was responsible for making certain that an independent examination of this proceedings was carried out in accordance with standards of the National Academies and that all review comments were carefully considered. Responsibility for the final content rests entirely with the rapporteurs and the National Academies.
This page intentionally left blank.
Acknowledgments
A number of individuals contributed to the development of this workshop and proceedings. These include a number of staff members from the Health and Medicine Division and the National Academies of Sciences, Engineering, and Medicine: Jeanay Butler, Daniel Cesnalis, Liza Hamilton, Claire Moerder, Julie Pavlin, Katherine Perez, Bettina Seliber, Rachel M. Taylor, and Taryn Young. The planning committee contributed several hours of service to develop and execute the agenda. Reviewers also provided thoughtful remarks on the draft manuscript.
The overall successful functioning of the Forum on Public–Private Partnerships for Global Health and Safety (PPP Forum) and its activities depends on the generosity of its sponsors. Financial support for the PPP Forum is provided by Anheuser-Busch InBev; Becton, Dickinson and Company; Bill & Melinda Gates Foundation; Catholic Health Association of the United States; ExxonMobil; Global Health Innovative Technology Fund; Intel Corporation; Johnson & Johnson; Medtronic; Merck & Co., Inc.; Novartis Foundation; PATH; Procter & Gamble Company; Safaricom; United Nations Foundation; University of Notre Dame; The UPS Foundation; U.S. Agency for International Development; U.S. Centers for Disease Control and Prevention; and U.S. Department of State.
This page intentionally left blank.
Contents
Organization of the Proceedings
2 MODELS FOR MULTI-SECTORAL ENGAGEMENT IN GLOBAL HEALTH: CHALLENGES AND OPPORTUNITIES
3 MULTI-SECTORAL ENGAGEMENT IN GLOBAL HEALTH: A PERSPECTIVE FROM INDUSTRY LEADERSHIP
Value Proposition for Industry Engagement in Global Health and Safety
4 VALUE PROPOSITION FOR MULTI-SECTORAL ENGAGEMENT IN GLOBAL HEALTH
5 APPROACHES AND MODELS FOR MULTI-SECTORAL ENGAGEMENT
Organizational Approaches for Multi-Sectoral Engagement
Models of Multi-Sectoral Engagement and Value Creation
6 INNOVATION IN MULTI-SECTORAL ENGAGEMENT IN GLOBAL HEALTH
Collaboration and Expansion in the Use of Drone Technology for Global Health
Expanded Special Project for Elimination of Neglected Tropical Diseases
Key Messages from the Workshop and Priority Actions and Strategies
Boxes and Figures
BOXES
4-1 Objectives for Session 1: Value Proposition for Multi-Sectoral Engagement in Global Health
5-1 Objectives for Session 2: Approaches and Models for Multi-Sectoral Engagement
6-1 Objectives for Session 3: Innovation in Multi-Sectoral Engagement in Global Health
7-1 Objectives for Session 4: Actionable Recommendations for the Way Forward
FIGURES
3-1 CD4 cell recovery following treatment
3-2 Predicted sick days in the absence of treatment
3-3 Cumulative per patient difference in sick days between treated and modeled untreated
3-5 Road traffic death rate per 100,000 population
3-6 Driver behavior as cause for accidents and fatalities
5-1 UNICEF and Gates Foundation shared goals and partnership framework
Acronyms and Abbreviations
AMFm | Affordable Medicines Facility—malaria |
APC | advance purchase commitment |
APOC | African Programme for Onchocerciasis Control |
CEO | chief executive officer |
CMMB | Catholic Medical Mission Board |
DIAL | Digital Impact Alliance |
DNDi | Drugs for Neglected Diseases initiative |
ESPEN | Expanded Special Project for Elimination of Neglected Tropical Diseases |
FDA | U.S. Food and Drug Administration |
FENSA | Framework for Engagement with Non-State Actors |
GARDP | Global Antibiotic Research and Development Partnership |
IFC | International Finance Corporation |
LMIC | low- and middle-income country |
MMV | Medicines for Malaria Venture |
MSF | Médecins Sans Frontières (Doctors Without Borders) |
NCD | noncommunicable disease |
NGO | nongovernmental organization |
PDP | product development partnership |
PEPFAR | The U.S. President’s Emergency Plan for AIDS Relief |
PPP | public–private partnership |
PPP Forum | Forum on Public–Private Partnerships for Global Health and Safety |
PRC | Peer Review Committee |
R&D | research and development |
RUTF | ready-to-use therapeutic food |
SDG | Sustainable Development Goal |
TB | tuberculosis |
TDR | Special Programme for Research and Training in Tropical Diseases |
UHC | universal health coverage |
UNICEF | United Nations Children’s Fund |
UPS | United Parcel Service |
USAID | U.S. Agency for International Development |
WHO | World Health Organization |